Paige: Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry NEW YORK–(BUSINESS WIRE)–Paige, a global leader in AI applications in pathology, today...

PARIS, France and CAMBRIDGE, Mass. – Keen Eye, a leading AI company in digital pathology for clinical research and Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies,...

Proscia and Hamamatsu: Cooperation agreement expands access to unified solution for end-to-end workflow PHILADELPHIA – March 9, 2022 – Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K.,...

Data accessibility and interoperability will accelerate translational medicine and development of therapeutic breakthroughs January 13, 2022, Philadelphia, PA and San Francisco, CA – Proscia, the leader in digital and computational...

Paige Prostate was granted de novo marketing authorization from the FDA to aid in the primary diagnosis of prostate cancer. NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced...

Computational pathology, or the use of Artificial Intelligence (AI) in the field of histopathology, holds significant potential for healthcare. For many of us, this emerging, fast-developing discipline comes with many interrogations. For...